Kaplan-Meier survival curves and the log rank test

Slides:



Advertisements
Similar presentations
Industry Issues: Dataset Preparation for Time to Event Analysis Davis Gates Schering Plough Research Institute.
Advertisements

Surviving Survival Analysis
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
HSRP 734: Advanced Statistical Methods July 24, 2008.
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
بسم الله الرحمن الرحیم. Generally,survival analysis is a collection of statistical procedures for data analysis for which the outcome variable of.
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Main Points to be Covered
Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.
Biostatistics in Research Practice Time to event data Martin Bland Professor of Health Statistics University of York
BIOST 536 Lecture 3 1 Lecture 3 – Overview of study designs Prospective/retrospective  Prospective cohort study: Subjects followed; data collection in.
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Generalized Linear Models
Survival Analysis A Brief Introduction Survival Function, Hazard Function In many medical studies, the primary endpoint is time until an event.
Analysis of Complex Survey Data
Kaplan-Meier Estimation &Log-Rank Test Survival of Ventilated and Control Flies (Old Falmouth Line 107) R.Pearl and S.L. Parker (1922). “Experimental Studies.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
1 Survival Analysis Biomedical Applications Halifax SAS User Group April 29/2011.
NASSER DAVARZANI DEPARTMENT OF KNOWLEDGE ENGINEERING MAASTRICHT UNIVERSITY, 6200 MAASTRICHT, THE NETHERLANDS 22 OCTOBER 2012 Introduction to Survival Analysis.
G Lecture 121 Analysis of Time to Event Survival Analysis Language Example of time to high anxiety Discrete survival analysis through logistic regression.
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
HSRP 734: Advanced Statistical Methods July 17, 2008.
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
Pro gradu –thesis Tuija Hevonkorpi.  Basic of survival analysis  Weibull model  Frailty models  Accelerated failure time model  Case study.
Lecture 12: Cox Proportional Hazards Model
Introduction Sample Size Calculation for Comparing Strategies in Two-Stage Randomizations with Censored Data Zhiguo Li and Susan Murphy Institute for Social.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Some survival basics Developments from the Kaplan-Meier method October
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
Topic 19: Survival Analysis T = Time until an event occurs. Events are, e.g., death, disease recurrence or relapse, infection, pregnancy.
Statistical Criteria for Establishing Safety and Efficacy of Allergenic Products Tammy Massie, PhD Mathematical Statistician Team Leader Bacterial, Parasitic.
EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/2016.
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Carolinas Medical Center, Charlotte, NC Website:
Survival time treatment effects
An introduction to Survival analysis and Applications to Predicting Recidivism Rebecca S. Frazier, PhD JBS International.
From: Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseThe REDUCE Randomized Clinical Trial.
April 18 Intro to survival analysis Le 11.1 – 11.2
Survival Analysis Rick Chappell, Ph.D. Professor,
Survival curves We know how to compute survival curves if everyone reaches the endpoint so there is no “censored” data. Survival at t = S(t) = number still.
UK Renal Registry 10th Annual Report 2007
Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings.
Copyright © 2006 American Medical Association. All rights reserved.
Clinical outcome after SVR: Veterans Affairs
Copyright © 2009 American Medical Association. All rights reserved.
Generalized Linear Models
Copyright © 2013 American Medical Association. All rights reserved.
Statistics 103 Monday, July 10, 2017.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
LV5FU2-cisplatin followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: Preliminary results of a randomized phase III trial (FFCD.
Biostatistics Primer: What a Clinician Ought to Know: Hazard Ratios
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Trial profile GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Ruth H. Keogh, Sanja Stanojevic  Journal of Cystic Fibrosis 
Non-parametric methods in statistical testing
Where are we?.
Presentation transcript:

Kaplan-Meier survival curves and the log rank test Dr Douwe Postmus (d.postmus@umcg.nl)

Content What makes the analysis of time-to-event data special? Kaplan-Meier estimator of the survival curve Log rank test to compare the survival curves between two or more groups

Example Population: patients admitted to the hospital with symptoms of heart failure (HF) Outcome: time from hospital discharge to HF hospitalization or death from any cause Parameter of interest: survival curve S(t) Proportion of patients with an event time larger than t

Survival curve for the population Survival curve S(t): proportion of patients in the population with an event time larger than t 1-year survival: S(1)=0.72 2-year survival: S(2)=0.56 3-year survival: S(3)=0.45 4-year survival: S(4)=0.37 5-year survival: S(5)=0.30 S(t) is generally unknown and needs to be estimated from the data

Random sample of n=1000 Estimated survival based on the event times in the sample 1-year survival: 708 / 100 = 0.71 2-year survival: 542 / 100 = 0.54 3-year survival: 445 / 100 = 0.45 4-year survival: 370 / 100 = 0.37 5-year survival: 300 / 100 = 0.30

Actual versus estimated survival

Right censoring Administrative censoring: the event is observed only if it occurs prior to some pre-specified time Studies with a fixed follow-up time (e.g., maximum of 2 years per patient) Studies with a fixed duration (e.g., 5 years between start and end of study) Loss to follow-up: subjects who drop out from the study before it is terminated

Graphically Start of study End of study x o o censored o x x event x o

Random sample (n=1000) with right-censored observations

How to estimate the 1-year survival? For the 578 patients whose event times were observed we know that 296 survived for more than 1 year 282 experienced the event within the first year For the 442 patients whose event times were censored we know that 332 survived for more than 1 year 90 either experienced the event within the first year or survived for more than one year

1-year survival: lower and upper bounds Lower bound: count the 90 patients who either experienced the event within the first year or survived for more than one year as if they experienced the event Upper bound: count the 90 patients who either experienced the event within the first year or survived for more than one year as if they survived

Graphically

Estimation based on conditional probabilities Interval Survival at start interval n.risk n.event n.censored Hazard Survival at end interval 0 - 1 1 1000 282 90 282 / 1000 = 0.282 1*(1 - 0.282) = 0.718 1 - 2 0.718 628 137 64 137 / 628 = 0.218 0.718*(1 - 0.219) = 0.561 2 - 3 0.561 427 76 50 76 / 427 = 0.178 0.561*(1 - 0.178) = 0.461 3 - 4 0.461 301 56 46 56 / 301 = 0.186 0.461*(1 - 0.186) = 0.375 4 - 5 0.375 199 27 172 27 / 199 = 0.136 0.375*(1 - 0.136) = 0.324 Hazard: probability of experiencing the event within the interval conditional on being alive at the start of the interval

Actual versus estimated survival

Kaplan-Meier estimator Survival curve estimated based on conditional probabilities Takes all the unique event and censoring times and sorts them in ascending order (from low to high) Uses the periods between the sorted event and censoring times as the intervals

KM survival curve for the example (time in days instead of years)

Actual versus estimated survival

Creating KM survival curves in SPSS

Creating KM survival curves in SPSS

KM survival curves for the three groups

Log rank test

Limitations of the log rank test The log rank test can be used to compare the survival curves of two or more groups Stratification can be used to adjust for the effect of a second categorical covariate Treatment effect adjusted for gender (i.e., separate survival curves for male and female patients) Examples of research questions for which the log rank test cannot be used Is age associated with the time to HF hospitalization or death from any cause? Treatment effect adjusted for several covariates

Next lecture Date Location Speaker Topic 11 June TBD H. Burgerhof Meta-analyses on continuous outcomes, odds ratios, and diagnostic tests

contact: d.postmus@umcg.nl